Overall, circRNA-100338 is closely associated with poor prognosis of hepatitis B-related HCC by activating mTOR signaling pathway via circRNA-100338/miR-141-3p/RHEB axis. This evidence concerns the gene MTOR and hepatocellular carcinoma.